STOCK TITAN

DiaMedica Therapeutics to Report First Quarter 2021 Financials and Provide a Business Update May 6, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

DiaMedica Therapeutics Inc. (Nasdaq: DMAC) will release its first quarter 2021 financial results after markets close on May 5th. A live conference call is scheduled for May 6th at 7:00 AM CT to discuss the financial results and provide a business update. Interested participants can join via phone or through a webcast, which will also be available for playback on the company's website for 12 months. A telephonic replay will be accessible until May 13, 2021. For further details, visit www.diamedica.com.

Positive
  • None.
Negative
  • None.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that its first quarter 2021 financial results will be released after the markets close on Wednesday, May 5th. DiaMedica will host a live conference call on Thursday, May 6th at 7:00 AM Central Time to discuss its business update and financial results.

Conference Call details:

Date:

Thursday, May 6, 2021

Time:

7:00 AM CT / 8:00 AM ET

Web access:

https://event.on24.com/wcc/r/3081283/E7DD7636B9914C65BD79123196FDA60B

Dial In:

(866) 393-4306 (domestic)

(734) 385-2616 (international)

Conference ID:

2966016

Interested parties may access the conference call by dialing in or listening to the simultaneous webcast. Listeners should log on to the website or dial in 15 minutes prior to the call. The webcast will remain available for play back on our website, under investor relations - events and presentations, following the earnings call and for 12 months thereafter. A telephonic replay of the conference call will be available until May 13, 2021, by dialing (855) 859-2056 (US Toll Free), (404) 537-3406 (International), and entering the replay passcode: 2966016.

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC) is a clinical stage biopharmaceutical company focused on developing novel treatments to improve the lives of patients with neurological and chronic kidney diseases. To learn more about DiaMedica, please visit www.diamedica.com.

FAQ

When will DiaMedica Therapeutics release its first quarter 2021 financial results?

DiaMedica Therapeutics will release its first quarter 2021 financial results after markets close on May 5, 2021.

What time is the DiaMedica conference call on May 6, 2021?

The conference call is scheduled for May 6, 2021, at 7:00 AM Central Time.

How can I access the DiaMedica call on May 6, 2021?

You can access the DiaMedica call by dialing in or listening to the webcast available on their website.

Is there a replay available for the DiaMedica conference call?

Yes, a telephonic replay will be available until May 13, 2021.

What is DiaMedica Therapeutics focused on?

DiaMedica Therapeutics focuses on developing novel treatments for neurological disorders and chronic kidney diseases.

DiaMedica Therapeutics Inc.

NASDAQ:DMAC

DMAC Rankings

DMAC Latest News

DMAC Stock Data

205.81M
26.04M
26.23%
31.61%
0.41%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MINNEAPOLIS